Anil Chandraker, MD, is the Medical Director of the Kidney/Pancreas Transplant Program, Interim Director of the Transplant Research Center, and an Associate Professor of Medicine at Harvard Medical School. Dr. Chandraker has broad research interest in transplantation, including basic, translational and clinical research. In the lab, his research interest focuses on dissecting out the role of T-cell costimulatory pathways and the development of chronic rejection by using animal models of transplantation. Dr. Chandraker also is active in a number of clinical trials related to transplantation.
Edgar Louis Milford, MD, , is a transplant nephrologist and an immunogeneticist. Dr. Milford is the Director of the BWH Tissue Typing Laboratory and an Associate Professor of Medicine at Harvard Medical School. He has had a longstanding academic interest in the physiological, immunological, genetic, and racial factors that are important in kidney and stem cell transplant outcomes.
Jamil Azzi, MD, is a transplant nephrologist and an Instructor in Medicine at Harvard Medical School. Dr. Azzi also is the Program Director of the BWH Transplant Medicine Fellowship Program. Dr. Azzi’s research focus is on establishing novel therapeutic strategies in transplantation and in type 1 diabetes through nanotechnology. He also is studying the role of tolerance in organ transplantation.
Reza Abdi, MD, is a transplant nephrologist and an Associate Professor of Medicine at Harvard Medical School. Dr. Abdi’s research focuses on the role of ischemia reperfusion injuries in augmenting immunogenicity of allografts. He also has a research interest in the field of type 1 diabetes, examining the role of mesenchymal stem cells in down-regulating autoimmunity.
Jae Chang, MD, is a transplant nephrologist and our primary physician for pancreas transplantation. Dr. Chang’s research focuses on the role of proximal tubule injury in the pathogenesis of diabetic nephropathy. He is interested in studying the cellular and molecular mechanisms involved in the development of chronic kidney disease associated with diabetes.
Melissa Yeung, MD, is a transplant nephrologist and an Instructor in Medicine at Harvard Medical School. Dr. Yeung’s research focuses on identifying novel pathways to prevent rejection after transplantation while lessening the need for lifelong immunosuppression.
Andrew M. Siedlecki, MD is a transplant nephrologist and an Instructor in Medicine at Harvard Medical School. Dr. Siedlecki has research interests that include cardiovascular disease in patients with kidney disease, ischemia/reperfusion injury in native kidneys and allografts, and the reparative capacity of endothelial progenitor cells.
Alice M. Sheridan, MD, is a general nephrologist, an Assistant Professor of Medicine at Harvard Medical School, and a deputy editor of nephrology at UpToDate. Dr. Sheridan serves as our donor nephrologist to evaluate potential living donors. Dr. Sheridan has clinical interests in acute and chronic kidney disease and fluid and electrolyte disorder. Research interests include cell-signaling pathways that underlie kidney injury.